Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × OTHER_GOV × Hearing Loss × Clear all

Status

Sponsor Class

OTHER 9 NIH 2 OTHER_GOV 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 41 Neoplasms 28 Uterine Cervical Neoplasms 21 Prostatic Neoplasms 19 Carcinoma, Non-Small-Cell Lung 19 Stomach Neoplasms 17 Colorectal Neoplasms 17 Carcinoma, Hepatocellular 16 Multiple Myeloma 10 Recurrence 9 Ovarian Neoplasms 9 Esophageal Squamous Cell Carcinoma 9 Pancreatic Neoplasms 8 Lymphoma 8 Esophageal Neoplasms 8 Lung Neoplasms 7 Leukemia, Myeloid, Acute 7 Endometrial Neoplasms 7 Leukemia 6 Gastrointestinal Neoplasms 6 Triple Negative Breast Neoplasms 5 Rectal Neoplasms 5 Papillomavirus Infections 5 Hematologic Neoplasms 5 Disease 5 Colonic Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Brain Neoplasms 5 Urinary Bladder Neoplasms 4 Small Cell Lung Carcinoma 4

Interventions

Radiotherapy 1 Drug Therapy 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06551857 2025-04-16

CaSPiN

Turku University Hospital

Ototoxicity, Neoplasms, Hearing Loss, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡